SCHEMBL5485932

SCHEMBL5485932

CCOC1CCN(c2nc(C)nc3cc(Nc4ccc(F)cc4)ccc23)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR4 P51679 2/20 0.38
ENPP1 P22413 1/20 0.38
HRH4 Q9H3N8 4/20 0.37
HRH3 Q9Y5N1 2/20 0.37
KCNH2 Q12809 1/20 0.37
MEN1 O00255 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 2/20 0.35
HPGD P15428 2/20 0.35
TSHR P16473 2/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP3A4 P08684 1/20 0.35
HSD17B10 Q99714 1/20 0.35
KIT P10721 2/20 0.34
LMNA P02545 1/20 0.34
MAPK1 P28482 1/20 0.34
DHFR P00374 2/20 0.34
TERT O14746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5485928 1.00 CCR4 (0.38) CCR4ENPP1HRH4HRH3KCNH2
SCHEMBL5488392 0.85 PIK3CA (0.45) ENPP1HRH4HRH3KCNH2KIT
SCHEMBL5488400 0.85 PIK3CA (0.45) ENPP1HRH4HRH3KCNH2KIT
SCHEMBL5484991 0.81 ENPP1 (0.44) ENPP1HRH4HRH3KCNH2MEN1
SCHEMBL5484986 0.81 ENPP1 (0.44) ENPP1HRH4HRH3KCNH2MEN1
SCHEMBL5485648 0.81 HRH4 (0.42) ENPP1HRH4HRH3KCNH2MEN1
SCHEMBL5485646 0.81 HRH4 (0.42) ENPP1HRH4HRH3KCNH2MEN1
Hydrochloric Acid SCHEMBL5485950 0.80 HRH4 (0.41) ENPP1HRH4HRH3KCNH2MEN1
Hydrochloric Acid SCHEMBL5485955 0.80 HRH4 (0.41) ENPP1HRH4HRH3KCNH2MEN1
SCHEMBL6804083 0.80 HRH4 (0.36) ENPP1HRH4HRH3KCNH2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7205309-B2 Quinazoline derivatives HOFFMANN-LA ROCHE INC. (US) 2007-04-17 US disclosed
EP-1560816-A1 QUINAZOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-10 EP disclosed
US-20040029901-A1 Quinazoline derivatives HOFFMANN-LA ROCHE INC. 2004-02-12 US disclosed
WO-2004005265-A1 QUINAZOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-01-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040029901-A1 Quinazoline derivatives GPR119, NQO2, CYP7A1 CCR4 3875/4885ENPP1 4421/4885HRH4 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.